hsa_circ_0030998

ncRNA information

ncRNA name

hsa_circ_0030998

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-558

Cancer information

Cancer name

Lung Cancer

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

28

Male patients

18

Female patients

20(<=60)+26(>60)

Age range and number

Not available

Research information

PMID

Description

A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR-558

Tissue resource

pairs of surgically excised lung cancer and adjacent tissues

human bronchial epithelial cell lines HBE

lung cancer cell lines A549

lung cancer cell lines H1299

lung cancer cell lines H358

lung cancer cell lines PC9

human embryonic kidney cell lines 293T

Experiment

46


Institute

Tianjin First Central Hospital

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian